We are excited to introduce a new therapeutic option, originally developed for diabetes, Semaglutide now available for chronic weight management. Clinical studies have shown that patients with a BMI of 27 or higher can lose up to 15-20% of their weight on this medication over a 68 weeks. Currently, 70% of American adults are battling obesity or overweight conditions. Ongoing research underscores the effectiveness of semaglutide injections in aiding weight loss. This development is crucial in recognizing and treating obesity as a chronic metabolic disease, rather than solely relying on individual willpower and lifestyle modifications.